Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Not a Nice Time For Nimesulide? DTAB, CDSCO Recommend Stringent Restrictions

Farhat Nasim3 May 2025 7:31 PM IST

New Delhi: Nimesulide, a widely used painkiller in India, is facing renewed regulatory scrutiny over its safety profile, with India's apex drug...

'Ghatiya' Is Hyperbole, Not Defamation: HC Declines to Restrain Influencers' Criticism of Protein Supplement

Farhat Nasim1 May 2025 7:41 PM IST

New Delhi: In a significant ruling defining the boundaries of free speech and online criticism in the digital age, the Delhi High Court has refused to...

Delhi HC Orders Arbitration in Medikabazaar Board Dispute, Tiwari Challenges Termination

Farhat Nasim1 May 2025 7:01 PM IST

New Delhi: In a significant development in the ongoing corporate controversy at Medikabazaar, the Delhi High Court has admitted a petition filed...

Govt extends deadline for submitting applications under PLI Scheme

Govt Issues Export Guidelines for Doxycycline 100 mg Dispersible Tablets

Farhat Nasim30 April 2025 7:29 PM IST

New Delhi: The Directorate General of Foreign Trade (DGFT), under the Ministry of Commerce and Industry, has issued Public Notice No. 03/2025-26 dated...

Action taken against 694 manufacturing units since 2022: Minister

Minor Drug Law Violations Can Now Be Settled Without Trial: Health Ministry Issues Rules

Farhat Nasim28 April 2025 7:21 PM IST

New Delhi: The Ministry of Health and Family Welfare has notified the Drugs and Cosmetics (Compounding of Offences) Rules, 2025, allowing...

Medical Council Order not Tenable as binding for criminal negligence cases: Delhi HC

Cough Syrup Warning Will Not Affect Existing Stock: HC Relief to Glenmark, Zuventus

Farhat Nasim26 April 2025 7:09 PM IST

New Delhi: In a major relief to pharma companies Glenmark Pharmaceuticals Ltd. and Zuventus Healthcare Ltd., the Delhi High Court has ruled that the...

CDSCO Flags 7 Batches of Popular Medicines as Purportedly Spurious in December

Batch of Telma AM earlier classified as NSQ now flagged as Spurious

Farhat Nasim25 April 2025 8:30 PM IST

New Delhi: Through a recent revised Drug Alert for January 2025, the Central Drugs Standard Control Organisation (CDSCO) has classified a batch of...

Novo Nordisk Withdrawal to Reshape Insulin Market; Lupin's Huminsulin to Gain Spotlight

Farhat Nasim24 April 2025 6:29 PM IST

Mumbai: Amidst the ongoing news of conventional insulin market disruption and growing concern over potential shortages triggered by Novo...

Jubilant Chairman Cleared of Charges in Sexual Assault Case

Farhat Nasim22 April 2025 7:07 PM IST

New Delhi: Jubilant Pharmova Limited has officially announced that the allegations made against its Chairman, Shyam S Bhartia have been found to be...

Novo Nordisk Bets on Oral Wegovy to Take on Eli Lilly in US Obesity Market

As Ozempic, Wegovy Take Priority, Novo Nordisk Winds Down Insulin Portfolio In India

Farhat Nasim22 April 2025 7:04 PM IST

New Delhi: Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand. This...

Rs 278 Cr Indemnity Claim, Inflated GMV, Board Ouster: Inside the Medikabazaar Controversy

Farhat Nasim21 April 2025 4:49 PM IST

Delhi: Medikabazaar, a leading B2B medical supply chain platform in India, became embroiled in a significant controversy involving allegations of...

BAMS doctor who forced 5-year-old to smoke cigarette to cure cold suspended

Medical Ethics Breached: 9 Doctors Suspended, 50 pharma giants in dock for Unauthorised Drug Trials

Farhat Nasim21 April 2025 4:29 PM IST

A five-member panel found that the trials violated NMC and DCGI norms due to lack of regulatory approvals.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok